Page last updated: 2024-08-17

acetyl coenzyme a and Hyperlipidemias

acetyl coenzyme a has been researched along with Hyperlipidemias in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19904 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (25.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Chen, K; Jiang, X; Lu, Y; Saaoud, F; Shao, Y; Vazquez-Padron, R; Wang, H; Wu, S; Xu, K; Yang, X; Zhao, H1
Arany, Z; Gosis, B; Jang, C; Lee, G; Rabinowitz, JD; Shen, Y; Wada, S; Yang, S; Zeng, X; Zhang, Z1
Groot, PHE; Lalwani, ND; Pinkosky, SL; Steinberg, GR1
Chen, X; Tang, K; Wang, F; Xu, X; Zeng, Y1
Zakim, D1
Locher, JT; Maier, R; Stähelin, HB1
Arrigo, F; Consolo, F; Vitale, D1
Frerman, FE; Grossberg, SE; Roch, LA1

Reviews

1 review(s) available for acetyl coenzyme a and Hyperlipidemias

ArticleYear
Targeting ATP-Citrate Lyase in Hyperlipidemia and Metabolic Disorders.
    Trends in molecular medicine, 2017, Volume: 23, Issue:11

    Topics: Acetyl Coenzyme A; Animals; ATP Citrate (pro-S)-Lyase; Humans; Hyperlipidemias; Metabolic Diseases; Randomized Controlled Trials as Topic

2017

Trials

1 trial(s) available for acetyl coenzyme a and Hyperlipidemias

ArticleYear
[Proceedings: Effect of alufibrate (Atherolip) on pyruvate and lipoprotein metabolism in patients with hyperlipidemia type IV].
    Helvetica medica acta, 1974, Volume: 37, Issue:5-6

    Topics: Acetyl Coenzyme A; Acetyl-CoA Carboxylase; Clinical Trials as Topic; Clofibrate; Fatty Acids; Humans; Hyperlipidemias; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Placebos; Pyruvates

1974

Other Studies

6 other study(ies) available for acetyl coenzyme a and Hyperlipidemias

ArticleYear
Early hyperlipidemia triggers metabolomic reprogramming with increased SAH, increased acetyl-CoA-cholesterol synthesis, and decreased glycolysis.
    Redox biology, 2023, Volume: 64

    Topics: Acetyl Coenzyme A; Animals; Apolipoproteins E; Cholesterol; Diet, High-Fat; Glycolysis; Hyperlipidemias; Mice; NF-E2-Related Factor 2; S-Adenosylhomocysteine

2023
The small intestine shields the liver from fructose-induced steatosis.
    Nature metabolism, 2020, Volume: 2, Issue:7

    Topics: Acetyl Coenzyme A; Administration, Oral; Animals; Diet; Fatty Acids, Nonesterified; Fatty Liver; Fructokinases; Fructose; Gastrointestinal Microbiome; Humans; Hyperlipidemias; Intestine, Small; Lipogenesis; Metabolic Syndrome; Mice; Mice, Knockout; Mice, Transgenic

2020
Salusin-α attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low density lipoprotein receptor deficient mice.
    European journal of pharmacology, 2018, Jul-05, Volume: 830

    Topics: Acetyl Coenzyme A; Animals; Atherosclerosis; Carnitine O-Palmitoyltransferase; Cholesterol 7-alpha-Hydroxylase; Diet, High-Fat; Fatty Acid Synthases; Fatty Liver; Hyperlipidemias; Intercellular Signaling Peptides and Proteins; Interleukin-6; Lipids; Male; Mice, Knockout; PPAR alpha; Receptors, LDL; Tumor Necrosis Factor-alpha; Weight Gain

2018
The effect of fructose on hepatic synthesis of fatty acids.
    Acta medica Scandinavica. Supplementum, 1972, Volume: 542

    Topics: Acetyl Coenzyme A; Acetyl-CoA Carboxylase; Animals; Carbon Isotopes; Coenzyme A; Fatty Acid Synthases; Fatty Acids; Fructose; Glucokinase; Glucose; Glycolysis; Hexokinase; Humans; Hyperlipidemias; Ligases; Liver; Male; Phosphotransferases; Pyruvates; Rats; Stimulation, Chemical; Triglycerides

1972
[Preliminary research on the effects of administration of CoA on plasmatic lipids in humans].
    La Clinica terapeutica, 1974, Dec-15, Volume: 71, Issue:5

    Topics: Acetyl Coenzyme A; Aged; Cholesterol; Coenzyme A; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Male; Middle Aged; Triglycerides

1974
The inhibition of lipid-containing viruses by an antilipemic agent.
    Progress in immunobiological standardization, 1971, Volume: 5

    Topics: Acetyl Coenzyme A; Animals; Antiviral Agents; Arbovirus Infections; Arboviruses; Carboxy-Lyases; Chick Embryo; Hyperlipidemias; Hypolipidemic Agents; Liver; Propionates; West Nile virus

1971